Before we discuss this IPO, let’s understand some of the related basic details:
IPO Basic Details
Polycab India Limited
Book Building Offer
₹10 Per Equity Share
IPO Price Band
Neogen Chemicals Background
The company began its operations in the year 1991 in Navi Mumbai and is engaged in the manufacturing of bromine and lithium-based speciality chemicals, which are used for imparting various properties to different kinds of products.
Speciality chemicals products are organic and inorganic in nature and comprise pharmaceutical and agrochemical intermediates, polymers additives, etc. There are four manufacturing units of the company in Maharashtra and Gujarat and they are spread in a total of 40 acres.
They also have in-house research and development units.
Neogen Chemicals IPO Data Points
Neogen Chemicals IPO will open on (to be disclosed) and close for subscription on (to be disclosed).
The IPO size will be of (to be disclosed) lakh Equity shares and the face value of each share will be ₹10. The price band has been set at ₹(to be disclosed) – ₹(to be disclosed) per equity share. The offer price includes a premium of ₹(to be disclosed) and is (to be disclosed) times the face value of the equity shares. The IPO size is expected to be up to ₹(to be disclosed) lakhs.
The offer consists of a fresh issue of up to (to be disclosed) lakh equity shares aggregating up to ₹70 crores and an offer for sale of up to 29 lakh equity shares by selling shareholders.
Up to 16,99,600 equity shares, aggregating up to ₹(to be disclosed) crores are being offered by Haridas Thakarshi Kanani and the rest 12,00,400 equity shares by Beena Haridas Kanani. (to be disclosed) lakh equity shares, aggregating up to Rs. (to be disclosed) lakhs will be allocated to retail investors for up to ₹(to be disclosed) lakh.
The market lot size is of (to be disclosed) equity shares and the shares will be listed on the National Stock exchange (NSE) and the Bombay Stock Exchange (BSE).
Pursuant to a resolution passed on September 21, 2018, the fresh issue has been authorised by the Board of Directors and by the shareholders on October 16, 2018, pursuant to a special resolution of the shareholders at the Extraordinary General Meeting.
The selling shareholders, Haridas Thakarshi Kanani and Beena Haridas Kanani approved their sale of shares through their consent letters dated September 20, 2018.
Neogen Chemicals Financial Performance
The financial health of the company seems to be good by analysing the above-mentioned parameters.
(In ₹ Crores)
For the six months ended September 30, 2018
For the Financial Year Ended March 31 ,2018
For the Financial Year Ended March 31, 2017
For the Financial Year Ended March 31, 2016
For the Financial Year Ended March 31, 2015
Profit After Tax (PAT)
Basic Earnings Per Share (₹)
Total Revenues and profit after tax of the company have been increasing over the last few financial years. As per the restated consolidated financial statements, the return on net worth of the company for the fiscal years ended March 31, 2018, March 31, 2017, and March 31, 2016, are 20.98%, 18.31% and 18.8% respectively and for the period ended September 30, 2018, is 19.72%.
The NAV figures for the company for the fiscal years ended March 31, 2018, March 31, 2017, and March 31, 2016, and for the six months ended September 30, 2018, are 25.03, 20.98, 13.77 and 28.37.
Neogen Chemicals IPO Objectives
The Neogen Chemicals IPO consists of two parts:
The proceeds from the offer for sale of equity shares will be given to the selling shareholders. Any proceeds from the offer for sale will not be received by the company for its operations.
The main objectives of the fresh issue of shares are as follows:
For repayment or prepayment of some or all of the borrowings taken by the company from banks and financial institutions
For the early redemption of 9.8% FRCPS
For funding of the working capital requirements of the company
For meeting expenses related to the general corporate operations.
Other than the above-mentioned objectives, the company will also benefit in terms of enhanced corporate image, brand name and increased visibility through Neogen Chemicals IPO.
Neogen Chemicals IPO Events
In case you are interested to apply in this IPO, you must be aware of the specific dates when different activities related to this IPO come into play.
Here are specific dates for you:
Filing of Draft Red Herring Prospectus (DRHP)
November 5, 2018
IPO Open Date
IPO Close Date
Finalization of Basis of Allotment
Credit to Demat Accounts
Listing at BSE and NSE
Neogen Chemicals IPO Recommendation
Now, before deciding whether to invest in the Neogen Chemicals IPO or not, let us try to analyse various aspects of the company like its strengths and risks related to its business.
One of the biggest strengths of the company is its wide variety of products manufacturing a total of 187 products which include 170 organic and 17 inorganic chemicals. Due to this wide range of products, the customers they cater to are also diverse, which include pharmaceutical, agrochemical, construction chemicals etc.
Also, the in-house research and development capabilities of the team of the company carried out through 2 R&D facilities are another major strength that helps the company in its growth process.
Another major advantage for the company is the nature of the industry it operates in, which is highly technical and requires great precision and quality standards. This creates natural barriers for new entrants in the speciality chemicals industry. The company has been operating for the last many years and has been able to maintain good relationships with its suppliers.
Now, let us try to understand some of the major risks related to the business of the company.
The company and its promoters and directors, etc. are involved in certain legal proceedings pending at various stages and any adverse ruling in them may pose a risk to the overall profitability of the company.
The dependence on few sectors like pharma, agrochemicals, etc. is a risk factor for the company because any adverse development in these sectors may affect the business of Neogen Chemicals.
The manufacturing of speciality chemicals involves processes that can be dangerous as it involves the use of hazardous chemicals. Any loss of human life damage to the environment may impose penalties on the company.
Another major risk factor for the business of the company is its dependence on few clients for the majority of their revenues. The company has loans of around ₹103.07 crores including both secured and unsecured loans which expose the company to various risks.
Dependence on third party transport providers is another risk factor for the company. If the company is unable to meet the stringent quality standards or customer specifications regarding its products, it may adversely affect the profitability of the business.
The industry in which the company operates is highly competitive. Inability to compete effectively may result in a decrease of operating margins.
The company is exposed to the risk of foreign exchange rate fluctuations which may impact the business and profits of the company in a negative manner.
The company requires certain approvals, permits, licenses, etc. in order to operate smoothly. Any delay or failure in obtaining them may have a negative impact on the functioning of the company.
After analysing various important aspects of the company, it may be said that investors may choose to subscribe to the Neogen Chemicals IPO.
In case you are looking to invest in this IPO or any other upcoming IPO, let us assist you in taking the next steps forward.
Neogen Chemicals Management Information
Currently, there are 8 Directors on the Board of Neogen Chemicals. Haridas Thakarshi Kanani is the Chairman and Managing Director of Neogen Chemicals. He is a Chemical Engineer from IIT Bombay.
He is responsible for looking after manufacturing, research and development, general operations of the company along with the management functions related to the company’s manufacturing units.
Neogen Chemicals IPO Advisors Information
Inga Advisors Private Limited is acting as Book Running Lead Manager and Batlivala & Karani Securities India Private Limited is acting as co-book running lead manager to the issue. Link Intime India Private Limited is acting as the Registrar for the Neogen Chemicals IPO. Bharucha & Partners is acting as legal counsel to the offer.
Spice Route Legal is acting as legal counsel to the Promoters and Selling Shareholders. Squire Patton Boggs Singapore LLP is acting as Special Purpose International legal counsel to Inga Advisors Private Limited and Batlivala & Karani Securities India Private Limited.